Stay updated on Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.

Latest updates to the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page
- Check2 days agoChange DetectedThe page shows Revision: v3.3.4, replacing the earlier Revision: v3.3.3. This appears to be an administrative update to the page version and does not modify the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded the Locations section with Kansas sites (Fairway and Westwood) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and the Kansas Locations entry.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the banner about government funding and related operating-status notes from the page. Other content, including the study details and links, remains unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedNo significant changes detected between the two screenshots; the study record details (title, purpose, eligibility, interventions, and endpoints) remain unchanged.SummaryDifference0.5%

- Check102 days agoChange DetectedUpdated page now includes a government funding status notice and a new version v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

Stay in the know with updates to Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.